Echocardiographic Assessment of the Impact of Diabetes and Prognostic Analysis of Heart Transplantation
A Multicenter Clinical Study of Echocardiographic Evaluation of the Impact of Diabetes and Prognostic Analysis of Heart Transplantation
1 other identifier
observational
1,500
0 countries
N/A
Brief Summary
The aim of this study is to evaluat the impact of diabetes on cardiac function in patients with heart transplantation by multimodal imaging and analyse their prognosis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2021
Typical duration for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 11, 2021
CompletedFirst Posted
Study publicly available on registry
July 26, 2021
CompletedStudy Start
First participant enrolled
August 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2024
CompletedJuly 26, 2021
July 1, 2021
2.4 years
July 11, 2021
July 23, 2021
Conditions
Outcome Measures
Primary Outcomes (3)
all-cause mortality
death from all causes
up to 2023.12
acute rejection
acute rejection required treatment
up to 2023.12
readmission
readmission from all causes
up to 2023.12
Study Arms (3)
non-diabetes group
patients who underwent heart tranplantation without diabetes
pre-transplant diabetes group
patients who underwent heart tranplantation with diabetes before the transplantation
post transplant daibetes group
patients who underwent heart tranplantation without diabetes until after the transplantation
Eligibility Criteria
Adult patients who received a heart transplant after 2015
You may qualify if:
- Adult patients who received a heart transplant after 2015
You may not qualify if:
- The image quality is poor
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Xie Mingxinglead
- Second Affiliated Hospital, School of Medicine, Zhejiang Universitycollaborator
- Shanghai Zhongshan Hospitalcollaborator
- Wuhan Asia Heart Hospitalcollaborator
- Guangdong Provincial People's Hospitalcollaborator
- Henan Provincial People's Hospitalcollaborator
Study Officials
- PRINCIPAL INVESTIGATOR
Li Zhang, PhD
Department of Ultrasound, Union Hospital, Wuhan, China
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- MD, PhD,FACC, FAHA, FASE
Study Record Dates
First Submitted
July 11, 2021
First Posted
July 26, 2021
Study Start
August 1, 2021
Primary Completion
December 31, 2023
Study Completion
March 31, 2024
Last Updated
July 26, 2021
Record last verified: 2021-07
Data Sharing
- IPD Sharing
- Will not share